White Christopher G 4
4 · OCULAR THERAPEUTIX, INC · Filed Feb 1, 2023
Insider Transaction Report
Form 4
White Christopher G
Chief Business Officer
Transactions
- Award
Common Stock
2023-01-30+44,444→ 100,595 total - Award
Stock Option (Right to Buy)
2023-01-30+133,333→ 133,333 totalExercise: $3.88Exp: 2033-01-29→ Common Stock (133,333 underlying)
Footnotes (3)
- [F1]On January 30, 2023, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Company"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service to the Company, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter.
- [F2]Includes (i) 94,444 shares of common stock of the Company underlying unvested RSUs and (ii) 4,024 shares of the Company's common stock acquired under the 2014 Ocular Therapeutix, Inc. Employee Stock Purchase Plan on December 31, 2022.
- [F3]Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.